Gastrointestinal luminal toxins and proteins

Gastrointestinal luminal toxins and proteins represent a broad category of pathogenic or metabolic substances located within the gut lumen that serve as focal points for therapeutic intervention. This group includes bacterial exotoxins (such as Clostridioides difficile toxins A and B), dietary proteins (like gluten/gliadin in Celiac disease), and metabolic byproducts (such as ammonia, phosphate, or bile acids) that contribute to systemic or local disease states. Drugs targeting these entities typically function as binders, adsorbents, or neutralizing agents that act locally within the intestine to prevent the substances from interacting with the intestinal mucosa or being absorbed into the bloodstream. For example, phosphate binders are used in chronic kidney disease to manage hyperphosphatemia, while monoclonal antibodies like bezlotoxumab neutralize specific bacterial toxins to prevent recurrent infection. Because this term encompasses a heterogeneous group of molecules rather than a single receptor or enzyme, it is often classified as a functional target category in pharmacological contexts.

Other names

Enteric toxinsIntestinal luminal proteinsGut-derived toxinsDietary antigensBacterial exotoxins

Adsorption, chemical binding/sequestration, enzymatic degradation, or neutralization by monoclonal antibodies within the gastrointestinal tract to prevent systemic absorption or local mucosal damage.